| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |